Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Curr Ophthalmol Rep
Ipamorelin hits the GHRP receptor and says "release GH now." CJC-1295 (no DAC) hits the GHRH receptor and says "amplify that release." When dosed together: CJC-1295 primes the pituitary and increases the available pool of GH Ipamorelin triggers the acute release of that pool The combined pulse is substantially larger than either compound generates alone research suggests synergistic effects in the range of 210x depending on baseline GH status and dosing This works because the two compounds bind to completely separate receptors
Studies show that GHK-Cu is capable of altering the activity of more than 4,000 genes associated with regeneration, cell protection, and the formation of healthy tissue (Pickart et al., 2015)
Treatment with GLP-1RAs leads to rapid reduction in blood pressure, which, according to a meta-analysis (266), could substantially lower the risk of cardiovascular disease and mortality
US$ 25.25
US$ 24.91
US$ 23.33
US$ 27.32
US$ 20.91
